PARP1-IN-50
PARP1-IN-50 is a selective and orally active PARP-1 inhibitor with an IC50 of 64.98 nM. PARP1-IN-50 can inhibit PAR formation and induce DNA double strand breaks, thereby causing DNA damage. PARP1-IN-50 can induce G2/M phase arrest and cancer cells apoptosis. PARP1-IN-50 demonstrates significant antiproliferative activity against various cancer cells. PARP1-IN-50 can be used for the research of cancer, such as breast cancer[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; Bcl-2 Family; CDK; DNA/RNA Synthesis; PARP
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
NC(N/N=C/C1=CC(Br)=C(OCCCCOC2=C(C=C(C=C2Br)/C=N/NC(N)=S)OC)C(OC)=C1)=S
Molecular Formula
C22H26Br2N6O4S2
Molecular Weight
662.42
References & Citations
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-179614/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Bax; Bcl-2; CDK1; PARP1
CAS Number
[2255341-36-5]
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Polyclonal Antibody to Transforming Growth Factor Beta 1 Induced Transcript 1 (TGFb1I1)
Polyclonal Antibody to Transforming Growth Factor Beta 1 Induced Transcript 1 (TGFb1I1)
Polyclonal Antibody to Transforming Growth Factor Beta 1 Induced Transcript 1 (TGFb1I1)
Polyclonal Antibody to Transforming Growth Factor Beta 1 Induced Transcript 1 (TGFb1I1)
Polyclonal Antibody to Transforming Growth Factor Beta 1 Induced Transcript 1 (TGFb1I1)